Ayala Pharmaceuticals Inc (ADXS)

[raja48185]

India trial updates in Oct. wont move the pps needle as much.

Longs will have to wait till end of December when they have another update. That would give more time, more and importantly meaningful data and also much improved numbers (hopefully)for the market to take notice.

Going into Feb of next year when CIN data is released (and my guess is we will have another India trial update along with it)is when the rubber meets the road and ADXS has its best period - should the results be stellar.

On the other hand, there is going to be a BIG DILUTION between now and Feb. - the company needs money to keep the ongoing trials running smoothly, pay interest off their debt, operating expenses for salaries, fund the prostate cancer trials if they plan on starting them later during the year, may be pay off some more short term dues using more shares, etc.

Overall, future looks good, but dilution is going to pull back any movement or gain in pps, (should we have any going into the year end).